Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tappei Takada

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Nutrients|August 23, 2020
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary FlavonoidsHiroki Saito, Yu Toyoda, Hiroshi Hirata, et al.
Pharmaceutical Research|October 19, 2010
Human NPC1L1 expression is positively regulated by PPARαYuki Iwayanagi, Tappei Takada, Fumiya Tomura, et al.
Nutrients|March 12, 2022
Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos LeavesYu Toyoda, Tappei Takada, Hiroki Saito, et al.
Scientific Reports|April 6, 2017
VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the bodyHideaki Yamamoto, Tappei Takada, Yoshihide Yamanashi, et al.
Molecular Pharmacology|December 11, 2012
Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolitesTakashi Yoshikado, Tappei Takada, Hideaki Yamamoto, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 3, 2011
ABCG2/BCRP dysfunction as a major cause of goutHirotaka Matsuo, Tappei Takada, Kimiyoshi Ichida, et al.
Biochemical and Biophysical Research Communications|January 21, 2025
Luciferase-based bioluminescence revealed the facilitated diffusion of D-luciferin mediated by SLC17A3Keisuke Morita, Keisuke Sato, Ryuto Tomabechi, et al.
Leukemia & Lymphoma|December 22, 2025
Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphomaShuhei Matsumoto, Yuya Kurihara, Yasutaka Masuda, et al.
International Journal of Molecular Sciences|March 6, 2021
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset GoutYu Toyoda, Kateřina Pavelcová, Jana Bohatá, et al.
Pharmaceutical Research|February 19, 2015
Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated TransportNaoki Ito, Kousei Ito, Yuki Ikebuchi, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Nutrients|August 23, 2020
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary FlavonoidsHiroki Saito, Yu Toyoda, Hiroshi Hirata, et al.
Pharmaceutical Research|October 19, 2010
Human NPC1L1 expression is positively regulated by PPARαYuki Iwayanagi, Tappei Takada, Fumiya Tomura, et al.
Nutrients|March 12, 2022
Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos LeavesYu Toyoda, Tappei Takada, Hiroki Saito, et al.
Scientific Reports|April 6, 2017
VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the bodyHideaki Yamamoto, Tappei Takada, Yoshihide Yamanashi, et al.
Molecular Pharmacology|December 11, 2012
Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolitesTakashi Yoshikado, Tappei Takada, Hideaki Yamamoto, et al.
Nucleosides, Nucleotides & Nucleic Acids|December 3, 2011
ABCG2/BCRP dysfunction as a major cause of goutHirotaka Matsuo, Tappei Takada, Kimiyoshi Ichida, et al.
Biochemical and Biophysical Research Communications|January 21, 2025
Luciferase-based bioluminescence revealed the facilitated diffusion of D-luciferin mediated by SLC17A3Keisuke Morita, Keisuke Sato, Ryuto Tomabechi, et al.
Leukemia & Lymphoma|December 22, 2025
Prognostic impact of procarbazine in R-MPV followed by reduced-dose whole-brain radiotherapy and cytarabine for primary central nervous system lymphomaShuhei Matsumoto, Yuya Kurihara, Yasutaka Masuda, et al.
International Journal of Molecular Sciences|March 6, 2021
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset GoutYu Toyoda, Kateřina Pavelcová, Jana Bohatá, et al.
Pharmaceutical Research|February 19, 2015
Prediction of Drug Transfer into Milk Considering Breast Cancer Resistance Protein (BCRP)-Mediated TransportNaoki Ito, Kousei Ito, Yuki Ikebuchi, et al.
Pageof 16